J Endocrinol Invest:在两性中,视黄醇结合蛋白4(RBP4)均与代谢综合相关

2018-03-16 MedSci MedSci原创

在65岁及以上的白种人中,RBP4的血清水平与代谢综合症有关,独立于性和肾功能。高甘油三酯作为代谢综合征的一个组成部分与RBP4浓度的关系最为显著。

研究背景:最近的研究表明,升高的血浆视黄醇结合蛋白4(RBP4)成为代谢综合征(MS)的一个潜在危险因素。本研究旨在分析65岁及以上人群中血浆RBP4与代谢综合征之间的关系。

研究方法:本研究纳入3038例65岁及以上的参与者,男性参与者为1591例。测定血清脂质谱、RBP4浓度、葡萄糖、胰岛素、c反应蛋白、IL-6和氨基转移酶活性。评估营养状况(BMI/腰围)和他汀类药物和纤维蛋白的治疗。计算肾小球滤过率(eGFR)、de Ritis 比率、脂肪肝指数(FLI)和HOMA-IR。

研究结果:研究表明,在男性和女性参与者中,视黄醇结合蛋白4和代谢综合症均相关。男性的血浆RBP4水平至少增加了3X,而女性至少增加了4X。高甘油三酯血症与血浆RBP4水平升高密切相关。多变量、性别调整回归分析显示慢性肾病[比值比:1.86 (95% CI 1.78-1.94)]、高甘油三酯血症[比值比:1.24-1.87]]、高血压[比值比:1.15(1.24- 1.19)]、低血清HDL胆固醇[比值比:0.94(0.92-0.97)]、年龄> 80岁[比值比:0.86(0.81-0.90)]分别与RBP4浓度相关(均p < 0.001)。

研究结论:在65岁及以上的白种人中,RBP4的血清水平与代谢综合症有关,独立于性和肾功能。高甘油三酯作为代谢综合征的一个组成部分与RBP4浓度的关系最为显著。

原始出处

Majerczyk M, Kocelak P, Choreza P, et al. Components of metabolic syndrome in relation to plasma levels of retinol binding protein 4 (RBP4) in a cohort of people aged 65 years and older. J Endocrinol Invest, 2018, Mar 9. doi: 10.1007/s40618-018-0856-6.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1685760, encodeId=a59f1685e6005, content=<a href='/topic/show?id=33662108450' target=_blank style='color:#2F92EE;'>#两性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21084, encryptionId=33662108450, topicName=两性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b11728257119, createdName=ms117281293605716, createdTime=Thu Aug 16 21:17:00 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051097, encodeId=2b86205109e5a, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Mon Feb 18 11:17:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297504, encodeId=f28a29e5040e, content=不错的文章值得, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Sun Mar 18 23:08:03 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546208, encodeId=8e84154620844, content=<a href='/topic/show?id=54bc9090331' target=_blank style='color:#2F92EE;'>#视黄醇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90903, encryptionId=54bc9090331, topicName=视黄醇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=701f13898851, createdName=ms4468361851264128, createdTime=Sun Mar 18 12:17:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296957, encodeId=7a6529695e7d, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Mar 17 01:25:02 CST 2018, time=2018-03-17, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1685760, encodeId=a59f1685e6005, content=<a href='/topic/show?id=33662108450' target=_blank style='color:#2F92EE;'>#两性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21084, encryptionId=33662108450, topicName=两性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b11728257119, createdName=ms117281293605716, createdTime=Thu Aug 16 21:17:00 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051097, encodeId=2b86205109e5a, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Mon Feb 18 11:17:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297504, encodeId=f28a29e5040e, content=不错的文章值得, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Sun Mar 18 23:08:03 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546208, encodeId=8e84154620844, content=<a href='/topic/show?id=54bc9090331' target=_blank style='color:#2F92EE;'>#视黄醇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90903, encryptionId=54bc9090331, topicName=视黄醇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=701f13898851, createdName=ms4468361851264128, createdTime=Sun Mar 18 12:17:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296957, encodeId=7a6529695e7d, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Mar 17 01:25:02 CST 2018, time=2018-03-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1685760, encodeId=a59f1685e6005, content=<a href='/topic/show?id=33662108450' target=_blank style='color:#2F92EE;'>#两性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21084, encryptionId=33662108450, topicName=两性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b11728257119, createdName=ms117281293605716, createdTime=Thu Aug 16 21:17:00 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051097, encodeId=2b86205109e5a, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Mon Feb 18 11:17:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297504, encodeId=f28a29e5040e, content=不错的文章值得, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Sun Mar 18 23:08:03 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546208, encodeId=8e84154620844, content=<a href='/topic/show?id=54bc9090331' target=_blank style='color:#2F92EE;'>#视黄醇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90903, encryptionId=54bc9090331, topicName=视黄醇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=701f13898851, createdName=ms4468361851264128, createdTime=Sun Mar 18 12:17:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296957, encodeId=7a6529695e7d, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Mar 17 01:25:02 CST 2018, time=2018-03-17, status=1, ipAttribution=)]
    2018-03-18 1e1b8538m79(暂无匿称)

    不错的文章值得

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1685760, encodeId=a59f1685e6005, content=<a href='/topic/show?id=33662108450' target=_blank style='color:#2F92EE;'>#两性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21084, encryptionId=33662108450, topicName=两性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b11728257119, createdName=ms117281293605716, createdTime=Thu Aug 16 21:17:00 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051097, encodeId=2b86205109e5a, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Mon Feb 18 11:17:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297504, encodeId=f28a29e5040e, content=不错的文章值得, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Sun Mar 18 23:08:03 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546208, encodeId=8e84154620844, content=<a href='/topic/show?id=54bc9090331' target=_blank style='color:#2F92EE;'>#视黄醇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90903, encryptionId=54bc9090331, topicName=视黄醇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=701f13898851, createdName=ms4468361851264128, createdTime=Sun Mar 18 12:17:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296957, encodeId=7a6529695e7d, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Mar 17 01:25:02 CST 2018, time=2018-03-17, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1685760, encodeId=a59f1685e6005, content=<a href='/topic/show?id=33662108450' target=_blank style='color:#2F92EE;'>#两性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21084, encryptionId=33662108450, topicName=两性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b11728257119, createdName=ms117281293605716, createdTime=Thu Aug 16 21:17:00 CST 2018, time=2018-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051097, encodeId=2b86205109e5a, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Mon Feb 18 11:17:00 CST 2019, time=2019-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=297504, encodeId=f28a29e5040e, content=不错的文章值得, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Sun Mar 18 23:08:03 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546208, encodeId=8e84154620844, content=<a href='/topic/show?id=54bc9090331' target=_blank style='color:#2F92EE;'>#视黄醇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90903, encryptionId=54bc9090331, topicName=视黄醇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=701f13898851, createdName=ms4468361851264128, createdTime=Sun Mar 18 12:17:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296957, encodeId=7a6529695e7d, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Mar 17 01:25:02 CST 2018, time=2018-03-17, status=1, ipAttribution=)]
    2018-03-17 三生有幸9135

    学习一下谢谢分享

    0

相关资讯

Hypertension:高血压初始联合治疗降低更多危险

美国一项研究表明,初始联合治疗与心血管事件危险显著降低相关,更快达到血压靶目标对危险降低起主要贡献作用。该研究11月26日在线发表于《高血压》(Hypertension)杂志。临床试验提示,血压控制的时机是长期转归的重要决定因素,但真实世界的证据很少。研究者利用2005~2009年的电子医学表格回顾性分析了1762例初始联合治疗的成人血压升高患者,并与初始单药治疗后续转换为联合治疗的相似患者进行比

Hypertension:靶向交感神经消融可降低遗传盐敏感性高血压

交感神经系统在高血压人群和Dahl盐敏感高血压大鼠模型起着一定作用,但其中涉及哪些交感神经并不清楚。为阐述这一问题,美国明尼苏达大学的研究人员对肾脏和内脏交感神经在Dahl高血压小鼠模型中的作用进行验证,他们将实验模型分为假手术组(n=10),靶向肾交感神经消融组(肾脏去神经支配组, n=11),内脏神经消融组(腹腔神经节去除组,n=11),肾脏神经和腹腔神经联合消融组(n=11)。给予0.4%氯

Hypertension:高盐敏感性是主要特点,清晨理想收缩压<125 mmHg

近期,Hypertension杂志刊出了《改善亚洲高血压患者管理的共识文件》。上海交通大学医学院附属瑞金医院王继光教授参与了本共识的制定。

Hypertension:合并隐匿性高血压的糖尿病患者需进一步降压治疗

尽管大家对糖尿病患者隐匿性高血压(masked hypertension)的特点已经很清楚。然而对于这些患者临床上进行降压治疗的意义尚未完全清楚。IDACO研究(The current International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes )中的受试